Expensive therapies in children: Benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential
Meropi Toumba, Vasilis Kokotsis, Savvas C. Savva, Nicos Skordis
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Expensive therapies in children: Benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential'. Together they form a unique fingerprint.